Nephron Pharmaceuticals Corporation

ReCode Therapeutics , on track with its plan to take its two lead programs into the clinic this year, announced on 19 September that it raised another $50m in series B venture capital, bringing the ro

The US Food and Drug Administration continued to crack down on lack of sterility assurance, cross-contamination and poor investigations in recent inspection reports and warning letters to pharma compa

The US Food and Drug Administration is paying close attention to sponsored links for prescription drug products, issuing its third enforcement letter in the past 18 months objecting to a link on Googl

The US Food and Drug Administration’s Office of Prescription Drug Promotion issued six enforcement letters in 2020, just one more than the record low set in 2017. While citations declined they focused